SPDR S&P Pharmaceuticals ETF
XPH
XPH
75 hedge funds and large institutions have $182M invested in SPDR S&P Pharmaceuticals ETF in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 21 closing their positions.
Holders
75
Holders Change
-10
Holders Change %
-11.76%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
19
Reduced
28
Closed
21
Calls
–
Puts
$234K
Net Calls
-$234K
Net Calls Change
-$234K
Top Buyers
1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$25.1M |
2 |
BB
2
Bell Bank
Fargo,
North Dakota
|
$18.1M |
3 |
3
Morgan Stanley
New York
|
$34.2M |
4 |
4
BNP Paribas Financial Markets
Paris,
France
|
$8.37M |
5 |
5
Wells Fargo
San Francisco,
California
|
$8.3M |